Silverarc Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77M | Sell |
402,964
-906,260
| -69% | -$8.49M | 0.7% | 31 |
|
|
2025
Q1 | $16.1M | Buy |
1,309,224
+78,824
| +6% | +$968K | 3.29% | 9 |
|
|
2024
Q4 | $16.3M | Buy |
1,230,400
+851,654
| +225% | +$11.3M | 3.56% | 9 |
|
|
2024
Q3 | $7.29M | Buy |
378,746
+8,746
| +2% | +$168K | 1.64% | 18 |
|
|
2024
Q2 | $7.6M | Buy |
+370,000
| New | +$7.6M | 1.79% | 17 |
|
|
2023
Q4 | – | Sell |
-20,000
| Closed | -$290K | – | 80 |
|
|
2023
Q3 | $290K | Hold |
20,000
| – | – | 0.09% | 63 |
|
|
2023
Q2 | $419K | Buy |
+20,000
| New | +$419K | 0.13% | 65 |
|
|
2022
Q3 | – | Sell |
-107,852
| Closed | -$2.08M | – | 81 |
|
|
2022
Q2 | $2.08M | Buy |
107,852
+6,405
| +6% | +$123K | 0.64% | 31 |
|
|
2022
Q1 | $1.76K | Buy |
101,447
+1,447
| +1% | +$25 | 0.73% | 32 |
|
|
2021
Q4 | $2.19M | Buy |
+100,000
| New | +$2.19M | 0.89% | 36 |
|
|
2021
Q3 | – | Sell |
-34,727
| Closed | -$596 | – | 101 |
|
|
2021
Q2 | $596 | Buy |
34,727
+14,727
| +74% | +$253 | 0.27% | 72 |
|
|
2021
Q1 | $447K | Sell |
20,000
-10,000
| -33% | -$224K | 0.24% | 72 |
|
|
2020
Q4 | $667K | Buy |
+30,000
| New | +$667K | 0.39% | 61 |
|